

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 6.72603773 |
| 2 | muscle filament sliding (GO:0030049) | 6.72603773 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 6.20123998 |
| 4 | actin-mediated cell contraction (GO:0070252) | 5.44811435 |
| 5 | interferon-gamma secretion (GO:0072643) | 5.33537827 |
| 6 | regulation of mitochondrial translation (GO:0070129) | 5.20469275 |
| 7 | skeletal muscle contraction (GO:0003009) | 4.83163621 |
| 8 | maturation of SSU-rRNA (GO:0030490) | 4.79599929 |
| 9 | folic acid metabolic process (GO:0046655) | 4.66234406 |
| 10 | oxidative phosphorylation (GO:0006119) | 4.61282864 |
| 11 | tricarboxylic acid cycle (GO:0006099) | 4.48257823 |
| 12 | carnitine shuttle (GO:0006853) | 4.33038954 |
| 13 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.31690170 |
| 14 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.27902142 |
| 15 | sarcomere organization (GO:0045214) | 4.26683819 |
| 16 | formation of translation preinitiation complex (GO:0001731) | 4.23155836 |
| 17 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.22790647 |
| 18 | purine nucleotide salvage (GO:0032261) | 4.19766280 |
| 19 | plasma membrane repair (GO:0001778) | 4.18702590 |
| 20 | ribosomal large subunit biogenesis (GO:0042273) | 4.17160389 |
| 21 | NADH metabolic process (GO:0006734) | 4.15950621 |
| 22 | ribosomal small subunit assembly (GO:0000028) | 4.06538533 |
| 23 | folic acid transport (GO:0015884) | 4.04624077 |
| 24 | skeletal muscle adaptation (GO:0043501) | 4.04187299 |
| 25 | IMP metabolic process (GO:0046040) | 3.99100032 |
| 26 | skeletal muscle tissue regeneration (GO:0043403) | 3.95571113 |
| 27 | purine nucleobase biosynthetic process (GO:0009113) | 3.92867943 |
| 28 | actin filament-based movement (GO:0030048) | 3.86360240 |
| 29 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.85916853 |
| 30 | nucleobase biosynthetic process (GO:0046112) | 3.77739282 |
| 31 | ubiquinone biosynthetic process (GO:0006744) | 3.77547028 |
| 32 | quinone biosynthetic process (GO:1901663) | 3.77547028 |
| 33 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.77230595 |
| 34 | fatty acid transmembrane transport (GO:1902001) | 3.69498459 |
| 35 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.66223678 |
| 36 | ATP synthesis coupled proton transport (GO:0015986) | 3.66223678 |
| 37 | creatine metabolic process (GO:0006600) | 3.56766799 |
| 38 | regulation of cofactor metabolic process (GO:0051193) | 3.56682962 |
| 39 | regulation of coenzyme metabolic process (GO:0051196) | 3.56682962 |
| 40 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.56158563 |
| 41 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.55083648 |
| 42 | galactose catabolic process (GO:0019388) | 3.53620319 |
| 43 | ribosomal small subunit biogenesis (GO:0042274) | 3.51275941 |
| 44 | IMP biosynthetic process (GO:0006188) | 3.47897281 |
| 45 | respiratory electron transport chain (GO:0022904) | 3.44927100 |
| 46 | intestinal epithelial cell development (GO:0060576) | 3.41470244 |
| 47 | translational termination (GO:0006415) | 3.40075556 |
| 48 | ribosome assembly (GO:0042255) | 3.38997424 |
| 49 | striated muscle contraction (GO:0006941) | 3.38116009 |
| 50 | myofibril assembly (GO:0030239) | 3.35336976 |
| 51 | viral transcription (GO:0019083) | 3.35117576 |
| 52 | electron transport chain (GO:0022900) | 3.33760398 |
| 53 | carnitine transmembrane transport (GO:1902603) | 3.31534814 |
| 54 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.30639873 |
| 55 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.28604708 |
| 56 | AMP metabolic process (GO:0046033) | 3.28401590 |
| 57 | skeletal muscle fiber development (GO:0048741) | 3.27084920 |
| 58 | translational initiation (GO:0006413) | 3.20125438 |
| 59 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.19252277 |
| 60 | ubiquinone metabolic process (GO:0006743) | 3.17921677 |
| 61 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.14632263 |
| 62 | translational elongation (GO:0006414) | 3.12868761 |
| 63 | proteasome assembly (GO:0043248) | 3.12241886 |
| 64 | amino-acid betaine transport (GO:0015838) | 3.08000894 |
| 65 | carnitine transport (GO:0015879) | 3.08000894 |
| 66 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.07631304 |
| 67 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.07001794 |
| 68 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.06455727 |
| 69 | labyrinthine layer development (GO:0060711) | 3.05884811 |
| 70 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.00820424 |
| 71 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.96922073 |
| 72 | negative regulation of ligase activity (GO:0051352) | 2.96922073 |
| 73 | glycogen catabolic process (GO:0005980) | 2.96701634 |
| 74 | rRNA modification (GO:0000154) | 2.96184375 |
| 75 | regulation of sulfur metabolic process (GO:0042762) | 2.92665287 |
| 76 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.87316818 |
| 77 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.86188898 |
| 78 | positive regulation of ligase activity (GO:0051351) | 2.85487473 |
| 79 | actomyosin structure organization (GO:0031032) | 2.82302659 |
| 80 | mitotic metaphase plate congression (GO:0007080) | 2.80074769 |
| 81 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.79325173 |
| 82 | fructose metabolic process (GO:0006000) | 2.79169063 |
| 83 | glucan catabolic process (GO:0009251) | 2.77410028 |
| 84 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.76510509 |
| 85 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.76510509 |
| 86 | cardiac muscle cell development (GO:0055013) | 2.73586361 |
| 87 | translation (GO:0006412) | 2.73381985 |
| 88 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.73177113 |
| 89 | muscle contraction (GO:0006936) | 2.72406852 |
| 90 | 2-oxoglutarate metabolic process (GO:0006103) | 2.71965150 |
| 91 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.71580033 |
| 92 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.71580033 |
| 93 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.71250763 |
| 94 | DNA replication checkpoint (GO:0000076) | 2.69705074 |
| 95 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.68605179 |
| 96 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.68605179 |
| 97 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.68605179 |
| 98 | glycogen biosynthetic process (GO:0005978) | 2.67567800 |
| 99 | glucan biosynthetic process (GO:0009250) | 2.67567800 |
| 100 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.65227686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.32742064 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.00649903 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.80665078 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.48984411 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.46243379 |
| 6 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.18543554 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.16146763 |
| 8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.15751033 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.95623345 |
| 10 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.91193072 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.82532225 |
| 12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.82387688 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.78035709 |
| 14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.68037935 |
| 15 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.65122794 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.59873453 |
| 17 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.41102450 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.26800833 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.13934836 |
| 20 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.13096889 |
| 21 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.04091125 |
| 22 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.99800847 |
| 23 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.97823965 |
| 24 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.97423201 |
| 25 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.97141263 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.94446090 |
| 27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.84948031 |
| 28 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.84926287 |
| 29 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.83446401 |
| 30 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.78687603 |
| 31 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.72707574 |
| 32 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.67956798 |
| 33 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.67499457 |
| 34 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.66214744 |
| 35 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.62773535 |
| 36 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.60526338 |
| 37 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.56876101 |
| 38 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.54009991 |
| 39 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.52863639 |
| 40 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52462672 |
| 41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.52420334 |
| 42 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.52415443 |
| 43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.52227822 |
| 44 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.51264898 |
| 45 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.47101655 |
| 46 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.44787739 |
| 47 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.42967743 |
| 48 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.42160105 |
| 49 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.41055492 |
| 50 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.33673795 |
| 51 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.33457279 |
| 52 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.29573156 |
| 53 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27305409 |
| 54 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.26743142 |
| 55 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.26695639 |
| 56 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.25588630 |
| 57 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.25498143 |
| 58 | ATF3_27146783_Chip-Seq_COLON_Human | 1.22829819 |
| 59 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.22040875 |
| 60 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.21566519 |
| 61 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.20444433 |
| 62 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.14336238 |
| 63 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12404394 |
| 64 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.11835614 |
| 65 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.09428636 |
| 66 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.07386592 |
| 67 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.05778155 |
| 68 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04930320 |
| 69 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.04336124 |
| 70 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.03847319 |
| 71 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.03210033 |
| 72 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02101865 |
| 73 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.01759773 |
| 74 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01552999 |
| 75 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.00934375 |
| 76 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.99007028 |
| 77 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.98818079 |
| 78 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.98745307 |
| 79 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.98090839 |
| 80 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.97705622 |
| 81 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97661054 |
| 82 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.96411434 |
| 83 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.96106169 |
| 84 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95048144 |
| 85 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94284317 |
| 86 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94052775 |
| 87 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.92379851 |
| 88 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.92348785 |
| 89 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.86873341 |
| 90 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.86869217 |
| 91 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86688743 |
| 92 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86634648 |
| 93 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86504568 |
| 94 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86121993 |
| 95 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.85873979 |
| 96 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.85848188 |
| 97 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.84647615 |
| 98 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.84337646 |
| 99 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.84252390 |
| 100 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.83184091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 6.44389988 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 4.65555707 |
| 3 | MP0000751_myopathy | 4.58310836 |
| 4 | MP0000749_muscle_degeneration | 4.16034836 |
| 5 | MP0004036_abnormal_muscle_relaxation | 3.21852564 |
| 6 | MP0003693_abnormal_embryo_hatching | 3.10897608 |
| 7 | MP0000747_muscle_weakness | 3.07492587 |
| 8 | MP0002106_abnormal_muscle_physiology | 3.02561327 |
| 9 | MP0004087_abnormal_muscle_fiber | 2.82730781 |
| 10 | MP0002269_muscular_atrophy | 2.77504372 |
| 11 | MP0004185_abnormal_adipocyte_glucose | 2.72491680 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.67508336 |
| 13 | MP0004084_abnormal_cardiac_muscle | 2.58604749 |
| 14 | MP0004130_abnormal_muscle_cell | 2.56893850 |
| 15 | MP0000750_abnormal_muscle_regeneration | 2.55842458 |
| 16 | MP0005330_cardiomyopathy | 2.48958725 |
| 17 | MP0000759_abnormal_skeletal_muscle | 2.46274719 |
| 18 | MP0006036_abnormal_mitochondrial_physio | 2.46081868 |
| 19 | MP0005369_muscle_phenotype | 2.41912341 |
| 20 | MP0004957_abnormal_blastocyst_morpholog | 2.31742842 |
| 21 | MP0005620_abnormal_muscle_contractility | 2.29421226 |
| 22 | MP0003111_abnormal_nucleus_morphology | 2.11155978 |
| 23 | MP0009840_abnormal_foam_cell | 1.99306363 |
| 24 | MP0004215_abnormal_myocardial_fiber | 1.92269890 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.87222147 |
| 26 | MP0005666_abnormal_adipose_tissue | 1.85498124 |
| 27 | MP0003567_abnormal_fetal_cardiomyocyte | 1.81477639 |
| 28 | MP0003221_abnormal_cardiomyocyte_apopto | 1.73813844 |
| 29 | MP0005451_abnormal_body_composition | 1.66896477 |
| 30 | MP0004233_abnormal_muscle_weight | 1.64698320 |
| 31 | MP0000733_abnormal_muscle_development | 1.61137631 |
| 32 | MP0004484_altered_response_of | 1.57020579 |
| 33 | MP0006035_abnormal_mitochondrial_morpho | 1.54763406 |
| 34 | MP0010352_gastrointestinal_tract_polyps | 1.45720076 |
| 35 | MP0003123_paternal_imprinting | 1.45706591 |
| 36 | MP0010630_abnormal_cardiac_muscle | 1.44627843 |
| 37 | MP0001730_embryonic_growth_arrest | 1.44227595 |
| 38 | MP0003283_abnormal_digestive_organ | 1.42973523 |
| 39 | MP0001544_abnormal_cardiovascular_syste | 1.39712729 |
| 40 | MP0005385_cardiovascular_system_phenoty | 1.39712729 |
| 41 | MP0003077_abnormal_cell_cycle | 1.31684363 |
| 42 | MP0009379_abnormal_foot_pigmentation | 1.30925178 |
| 43 | MP0010094_abnormal_chromosome_stability | 1.29342996 |
| 44 | MP0002332_abnormal_exercise_endurance | 1.20923681 |
| 45 | MP0002972_abnormal_cardiac_muscle | 1.19717373 |
| 46 | MP0003941_abnormal_skin_development | 1.19090953 |
| 47 | MP0002234_abnormal_pharynx_morphology | 1.14941391 |
| 48 | MP0002971_abnormal_brown_adipose | 1.09250357 |
| 49 | MP0004134_abnormal_chest_morphology | 1.08344900 |
| 50 | MP0003950_abnormal_plasma_membrane | 1.07585368 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.06954896 |
| 52 | MP0002108_abnormal_muscle_morphology | 1.06842926 |
| 53 | MP0008775_abnormal_heart_ventricle | 1.04744199 |
| 54 | MP0005266_abnormal_metabolism | 1.01536796 |
| 55 | MP0005375_adipose_tissue_phenotype | 0.99638541 |
| 56 | MP0003137_abnormal_impulse_conducting | 0.95451188 |
| 57 | MP0000566_synostosis | 0.94219675 |
| 58 | MP0005332_abnormal_amino_acid | 0.92619522 |
| 59 | MP0003828_pulmonary_edema | 0.89591526 |
| 60 | MP0008058_abnormal_DNA_repair | 0.84201361 |
| 61 | MP0004019_abnormal_vitamin_homeostasis | 0.83713318 |
| 62 | MP0006138_congestive_heart_failure | 0.81154511 |
| 63 | MP0002088_abnormal_embryonic_growth/wei | 0.77880457 |
| 64 | MP0003718_maternal_effect | 0.77634470 |
| 65 | MP0003984_embryonic_growth_retardation | 0.75745508 |
| 66 | MP0000350_abnormal_cell_proliferation | 0.75559769 |
| 67 | MP0000762_abnormal_tongue_morphology | 0.75000782 |
| 68 | MP0003186_abnormal_redox_activity | 0.74721329 |
| 69 | MP0005085_abnormal_gallbladder_physiolo | 0.74198958 |
| 70 | MP0008932_abnormal_embryonic_tissue | 0.73100672 |
| 71 | MP0001672_abnormal_embryogenesis/_devel | 0.73052366 |
| 72 | MP0005380_embryogenesis_phenotype | 0.73052366 |
| 73 | MP0004197_abnormal_fetal_growth/weight/ | 0.72087522 |
| 74 | MP0001764_abnormal_homeostasis | 0.72018861 |
| 75 | MP0001697_abnormal_embryo_size | 0.71224093 |
| 76 | MP0002080_prenatal_lethality | 0.68318144 |
| 77 | MP0001853_heart_inflammation | 0.66915373 |
| 78 | MP0009672_abnormal_birth_weight | 0.66457511 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 0.66065439 |
| 80 | MP0010329_abnormal_lipoprotein_level | 0.65078402 |
| 81 | MP0000013_abnormal_adipose_tissue | 0.64967569 |
| 82 | MP0000537_abnormal_urethra_morphology | 0.63452362 |
| 83 | MP0002086_abnormal_extraembryonic_tissu | 0.62657957 |
| 84 | MP0000266_abnormal_heart_morphology | 0.62218204 |
| 85 | MP0002127_abnormal_cardiovascular_syste | 0.61756603 |
| 86 | MP0003119_abnormal_digestive_system | 0.60565786 |
| 87 | MP0004147_increased_porphyrin_level | 0.59222120 |
| 88 | MP0008007_abnormal_cellular_replicative | 0.57610766 |
| 89 | MP0002796_impaired_skin_barrier | 0.57098307 |
| 90 | MP0003315_abnormal_perineum_morphology | 0.55198250 |
| 91 | MP0003786_premature_aging | 0.55060468 |
| 92 | MP0001756_abnormal_urination | 0.54038506 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.52782121 |
| 94 | MP0008877_abnormal_DNA_methylation | 0.52298750 |
| 95 | MP0002210_abnormal_sex_determination | 0.50755593 |
| 96 | MP0000358_abnormal_cell_content/ | 0.50621049 |
| 97 | MP0002085_abnormal_embryonic_tissue | 0.49011193 |
| 98 | MP0001299_abnormal_eye_distance/ | 0.48157714 |
| 99 | MP0002009_preneoplasia | 0.48025720 |
| 100 | MP0000462_abnormal_digestive_system | 0.47204427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Muscle fiber inclusion bodies (HP:0100299) | 7.90525981 |
| 2 | * Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.42604870 |
| 3 | * Nemaline bodies (HP:0003798) | 7.10473636 |
| 4 | Exercise-induced myalgia (HP:0003738) | 6.98396670 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 6.09148890 |
| 6 | Type 1 muscle fiber predominance (HP:0003803) | 5.57064376 |
| 7 | Myopathic facies (HP:0002058) | 5.53895753 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.35200011 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 4.94605749 |
| 10 | Myoglobinuria (HP:0002913) | 4.72590608 |
| 11 | Distal arthrogryposis (HP:0005684) | 4.66443377 |
| 12 | Muscle fiber splitting (HP:0003555) | 4.54681602 |
| 13 | Ulnar deviation of the wrist (HP:0003049) | 4.53467605 |
| 14 | Rhabdomyolysis (HP:0003201) | 4.34025023 |
| 15 | Calcaneovalgus deformity (HP:0001848) | 3.91760517 |
| 16 | * Difficulty running (HP:0009046) | 3.75584145 |
| 17 | Deformed tarsal bones (HP:0008119) | 3.60156388 |
| 18 | * Muscle stiffness (HP:0003552) | 3.53173212 |
| 19 | Absent phalangeal crease (HP:0006109) | 3.46135238 |
| 20 | Hyporeflexia of lower limbs (HP:0002600) | 3.45843124 |
| 21 | Round ear (HP:0100830) | 3.37748750 |
| 22 | Areflexia of lower limbs (HP:0002522) | 3.34445663 |
| 23 | EMG: myopathic abnormalities (HP:0003458) | 3.31171723 |
| 24 | Abnormality of the calf musculature (HP:0001430) | 3.28085159 |
| 25 | Increased connective tissue (HP:0009025) | 3.25513638 |
| 26 | Hepatic necrosis (HP:0002605) | 3.13966133 |
| 27 | Rimmed vacuoles (HP:0003805) | 3.12645580 |
| 28 | * Neck muscle weakness (HP:0000467) | 3.12342090 |
| 29 | Myotonia (HP:0002486) | 2.99823329 |
| 30 | Increased muscle lipid content (HP:0009058) | 2.92543111 |
| 31 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.90161217 |
| 32 | Abnormality of alanine metabolism (HP:0010916) | 2.90161217 |
| 33 | Hyperalaninemia (HP:0003348) | 2.90161217 |
| 34 | Progressive muscle weakness (HP:0003323) | 2.83856836 |
| 35 | Abnormal finger flexion creases (HP:0006143) | 2.82095209 |
| 36 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.80379732 |
| 37 | Sudden death (HP:0001699) | 2.80232935 |
| 38 | Increased intramyocellular lipid droplets (HP:0012240) | 2.80205007 |
| 39 | Hepatocellular necrosis (HP:0001404) | 2.70909921 |
| 40 | Shoulder girdle muscle weakness (HP:0003547) | 2.66999463 |
| 41 | Abnormality of the calcaneus (HP:0008364) | 2.61618116 |
| 42 | Pelvic girdle muscle weakness (HP:0003749) | 2.59421068 |
| 43 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.56605171 |
| 44 | Dicarboxylic aciduria (HP:0003215) | 2.56605171 |
| 45 | Malignant hyperthermia (HP:0002047) | 2.47961186 |
| 46 | Lipid accumulation in hepatocytes (HP:0006561) | 2.47665235 |
| 47 | Subaortic stenosis (HP:0001682) | 2.44072088 |
| 48 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.44072088 |
| 49 | * Difficulty climbing stairs (HP:0003551) | 2.43587189 |
| 50 | Increased variability in muscle fiber diameter (HP:0003557) | 2.41651338 |
| 51 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.41572002 |
| 52 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.41572002 |
| 53 | Ventricular fibrillation (HP:0001663) | 2.40836910 |
| 54 | Increased hepatocellular lipid droplets (HP:0006565) | 2.34692510 |
| 55 | Colon cancer (HP:0003003) | 2.34129815 |
| 56 | Exercise intolerance (HP:0003546) | 2.27212772 |
| 57 | Paralysis (HP:0003470) | 2.18410853 |
| 58 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.14055951 |
| 59 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.14055951 |
| 60 | Trismus (HP:0000211) | 2.13164395 |
| 61 | Carpal bone hypoplasia (HP:0001498) | 2.11381274 |
| 62 | Ventricular tachycardia (HP:0004756) | 2.09677090 |
| 63 | Facial diplegia (HP:0001349) | 2.06984308 |
| 64 | Increased CSF lactate (HP:0002490) | 2.05211039 |
| 65 | Proximal tubulopathy (HP:0000114) | 2.03840579 |
| 66 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.03246885 |
| 67 | Mitochondrial inheritance (HP:0001427) | 2.02811368 |
| 68 | Abnormality of glycolysis (HP:0004366) | 2.01207057 |
| 69 | Increased serum pyruvate (HP:0003542) | 2.01207057 |
| 70 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.98369945 |
| 71 | Hypoglycemic coma (HP:0001325) | 1.98141621 |
| 72 | Palpitations (HP:0001962) | 1.96564215 |
| 73 | Bundle branch block (HP:0011710) | 1.95937745 |
| 74 | Achilles tendon contracture (HP:0001771) | 1.95346937 |
| 75 | Asymmetric septal hypertrophy (HP:0001670) | 1.94797016 |
| 76 | Hyperglycinuria (HP:0003108) | 1.94568879 |
| 77 | Distal lower limb muscle weakness (HP:0009053) | 1.94402784 |
| 78 | Lactic acidosis (HP:0003128) | 1.93659175 |
| 79 | Lipoatrophy (HP:0100578) | 1.90449829 |
| 80 | Hypoplastic ischia (HP:0003175) | 1.90437237 |
| 81 | Slender build (HP:0001533) | 1.89465300 |
| 82 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.89392775 |
| 83 | Increased serum lactate (HP:0002151) | 1.89060165 |
| 84 | Hip contracture (HP:0003273) | 1.88557878 |
| 85 | Acute necrotizing encephalopathy (HP:0006965) | 1.87580291 |
| 86 | Double outlet right ventricle (HP:0001719) | 1.86580964 |
| 87 | Congenital malformation of the right heart (HP:0011723) | 1.86580964 |
| 88 | Ventricular arrhythmia (HP:0004308) | 1.86125002 |
| 89 | Right ventricular cardiomyopathy (HP:0011663) | 1.85460548 |
| 90 | Reticulocytopenia (HP:0001896) | 1.82923549 |
| 91 | Hypoalphalipoproteinemia (HP:0003233) | 1.81838105 |
| 92 | Limb-girdle muscle weakness (HP:0003325) | 1.81618424 |
| 93 | Abnormality of the Achilles tendon (HP:0005109) | 1.80673026 |
| 94 | Gout (HP:0001997) | 1.79739407 |
| 95 | Generalized aminoaciduria (HP:0002909) | 1.78020353 |
| 96 | Abnormality of glycine metabolism (HP:0010895) | 1.77518828 |
| 97 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.77518828 |
| 98 | Cerebral edema (HP:0002181) | 1.76979341 |
| 99 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.76629663 |
| 100 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.74409883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.50860564 |
| 2 | NME1 | 4.82539849 |
| 3 | TTN | 3.78729652 |
| 4 | BUB1 | 3.61758432 |
| 5 | WEE1 | 3.51870788 |
| 6 | NEK1 | 2.91455715 |
| 7 | EPHA2 | 2.87175818 |
| 8 | PHKG1 | 2.84250732 |
| 9 | PHKG2 | 2.84250732 |
| 10 | CDK12 | 2.64080008 |
| 11 | BCKDK | 2.51858075 |
| 12 | PDK4 | 2.38005344 |
| 13 | PDK3 | 2.38005344 |
| 14 | MAP2K3 | 2.24028387 |
| 15 | ZAK | 2.03457187 |
| 16 | MAP3K3 | 2.03360242 |
| 17 | PIK3CG | 1.90250680 |
| 18 | PNCK | 1.83979691 |
| 19 | NME2 | 1.81911540 |
| 20 | NEK2 | 1.60648398 |
| 21 | PDK2 | 1.45127609 |
| 22 | PKN2 | 1.43516379 |
| 23 | BRSK2 | 1.41118097 |
| 24 | TTK | 1.40378394 |
| 25 | TRIB3 | 1.38036650 |
| 26 | RPS6KB2 | 1.26132250 |
| 27 | IRAK3 | 1.24025745 |
| 28 | PLK4 | 1.22344710 |
| 29 | STK24 | 1.15928688 |
| 30 | EIF2AK1 | 1.09818482 |
| 31 | MAP2K6 | 1.08459915 |
| 32 | MST1R | 1.08259345 |
| 33 | MAP3K11 | 0.99381531 |
| 34 | DYRK3 | 0.98299135 |
| 35 | STK38L | 0.98057036 |
| 36 | MAP3K7 | 0.93533328 |
| 37 | STK16 | 0.81039267 |
| 38 | CDC7 | 0.79212083 |
| 39 | DMPK | 0.77760322 |
| 40 | CDK7 | 0.77032826 |
| 41 | PLK1 | 0.76060828 |
| 42 | ILK | 0.75842576 |
| 43 | RPS6KA4 | 0.74978079 |
| 44 | PRKCI | 0.72942554 |
| 45 | AURKA | 0.72643328 |
| 46 | CCNB1 | 0.70882609 |
| 47 | PINK1 | 0.70739179 |
| 48 | AURKB | 0.70484422 |
| 49 | SRPK1 | 0.69257144 |
| 50 | CDK8 | 0.69175017 |
| 51 | MARK1 | 0.67906367 |
| 52 | BRSK1 | 0.67481822 |
| 53 | SCYL2 | 0.67046952 |
| 54 | PIK3CA | 0.65605912 |
| 55 | TESK2 | 0.65401683 |
| 56 | TAOK1 | 0.65064459 |
| 57 | MAP3K10 | 0.63456204 |
| 58 | MAPK12 | 0.63190716 |
| 59 | ABL2 | 0.61530579 |
| 60 | MAPK11 | 0.61205167 |
| 61 | KDR | 0.56207475 |
| 62 | CAMK2G | 0.55295094 |
| 63 | MAP2K4 | 0.55285308 |
| 64 | MARK3 | 0.54359678 |
| 65 | CDK4 | 0.53118850 |
| 66 | MAP2K2 | 0.51097651 |
| 67 | TSSK6 | 0.49761530 |
| 68 | NEK9 | 0.48658699 |
| 69 | LATS2 | 0.43442240 |
| 70 | KSR1 | 0.42867552 |
| 71 | MAP3K5 | 0.42835578 |
| 72 | MAP3K8 | 0.41667327 |
| 73 | CHEK2 | 0.41575612 |
| 74 | FLT3 | 0.38909410 |
| 75 | PAK4 | 0.37950240 |
| 76 | MELK | 0.37062898 |
| 77 | MYLK | 0.36259342 |
| 78 | MAPKAPK3 | 0.33639317 |
| 79 | AKT2 | 0.32852675 |
| 80 | TAOK2 | 0.31145592 |
| 81 | PRKAA1 | 0.30019205 |
| 82 | CAMK2D | 0.29792311 |
| 83 | PAK1 | 0.28798831 |
| 84 | PLK3 | 0.27238485 |
| 85 | CAMK1 | 0.26953809 |
| 86 | CSNK1E | 0.25272644 |
| 87 | CSNK2A2 | 0.24945889 |
| 88 | BRAF | 0.24937678 |
| 89 | LIMK1 | 0.24755734 |
| 90 | ATR | 0.24697930 |
| 91 | MAPK4 | 0.24196883 |
| 92 | TLK1 | 0.22473642 |
| 93 | EIF2AK3 | 0.22378820 |
| 94 | CHEK1 | 0.21873444 |
| 95 | PRKAA2 | 0.21871960 |
| 96 | PBK | 0.21066973 |
| 97 | EEF2K | 0.20888530 |
| 98 | CSNK2A1 | 0.18412367 |
| 99 | CDK2 | 0.15981140 |
| 100 | MET | 0.14203104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.39936254 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.91183492 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.21328569 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.03779495 |
| 5 | Carbon metabolism_Homo sapiens_hsa01200 | 2.62696067 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.51428102 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.44749111 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.36033893 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.34902685 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.25269753 |
| 11 | DNA replication_Homo sapiens_hsa03030 | 2.17602925 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.14150444 |
| 13 | Mismatch repair_Homo sapiens_hsa03430 | 2.13668933 |
| 14 | RNA polymerase_Homo sapiens_hsa03020 | 2.02575907 |
| 15 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.90563330 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.85024133 |
| 17 | RNA transport_Homo sapiens_hsa03013 | 1.84026395 |
| 18 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.81246462 |
| 19 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.79744876 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.77835086 |
| 21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.74074015 |
| 22 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.70952526 |
| 23 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.67644132 |
| 24 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.62926177 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.59507795 |
| 26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.58276784 |
| 27 | Galactose metabolism_Homo sapiens_hsa00052 | 1.58246056 |
| 28 | Base excision repair_Homo sapiens_hsa03410 | 1.47643608 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.43463259 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42171408 |
| 31 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.41824345 |
| 32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.40466399 |
| 33 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.39239304 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23956852 |
| 35 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.23956386 |
| 36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.21694292 |
| 37 | Spliceosome_Homo sapiens_hsa03040 | 1.19012532 |
| 38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.18541929 |
| 39 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.17485236 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.15420953 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.15160049 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.14602956 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09773122 |
| 44 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.09286310 |
| 45 | Tight junction_Homo sapiens_hsa04530 | 1.07229332 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.06029140 |
| 47 | Purine metabolism_Homo sapiens_hsa00230 | 1.04095927 |
| 48 | Cell cycle_Homo sapiens_hsa04110 | 1.01145283 |
| 49 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.96916698 |
| 50 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.94195495 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 0.83376085 |
| 52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.82014329 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80877437 |
| 54 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.78245174 |
| 55 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.76229036 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.74568842 |
| 57 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74132722 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.70807008 |
| 59 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68602252 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.68174727 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 0.66925409 |
| 62 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64431077 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62275178 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.62188271 |
| 65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60520043 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59998868 |
| 67 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.59337489 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58498824 |
| 69 | Basal transcription factors_Homo sapiens_hsa03022 | 0.57174850 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57045157 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55299366 |
| 72 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.53016066 |
| 73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53000699 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49814659 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.48585815 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47760182 |
| 77 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.47307011 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 0.45734763 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44473815 |
| 80 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.43349569 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43324255 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42039120 |
| 83 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40291167 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40268431 |
| 85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37446322 |
| 86 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.34975402 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34696502 |
| 88 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.34546303 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.32432397 |
| 90 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.30091065 |
| 91 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.27561482 |
| 92 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.22885109 |
| 93 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.22432612 |
| 94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.21950064 |
| 95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.21562787 |
| 96 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.21240234 |
| 97 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.19223636 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.19114437 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.18499885 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.18414366 |

